Privi Speciality Chemicals Reports ₹84.26 Crore Profit for June Quarter

Standalone net profit ₹84.26 crore; Consolidated net profit ₹82.84 crore.

Reader Takeaway: Strong profit performance alongside significant corporate restructuring via amalgamation.

What just happened

Privi Speciality Chemicals Ltd has announced its financial results for the quarter ended June 30, 2026. The company reported a standalone revenue of ₹600.59 crore and a standalone net profit of ₹84.26 crore. On a consolidated basis, revenue stood at ₹666.22 crore, with a net profit of ₹82.84 crore. The company operates in the 'Aroma Chemical' segment.

Why this matters

These results offer investors a clear view of the company's financial performance during the quarter. The profit figures indicate sustained operational efficiency. The update on the amalgamation scheme is a key corporate event that could impact the company's structure and future prospects.

The backstory

Privi Speciality Chemicals is involved in the aroma chemicals sector. The company is currently undertaking a significant restructuring through the amalgamation of its subsidiaries, Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited.

What changes now

The amalgamation scheme has been filed with the NCLT, Mumbai Bench, on June 25, 2026, following positive observations from stock exchanges in May 2026. This process is expected to streamline the company's operations. Additionally, the Board has recommended a final dividend of ₹10 per equity share for FY2026, pending shareholder approval.

Risks to watch

Investors will be closely watching the progress and timeline of the NCLT-approved amalgamation process, as delays could impact integration benefits. Economic slowdowns impacting demand for aroma chemicals could also pose a risk.

Peer comparison

While specific peer results for the same quarter are not detailed in the filing, Privi Speciality Chemicals operates in the aroma chemicals space, competing with other players in the speciality chemicals industry.

Context metrics (time-bound)

• Quarter Ended: June 30, 2026
• Standalone Revenue: ₹600.59 crore
• Standalone Net Profit: ₹84.26 crore
• Consolidated Revenue: ₹666.22 crore
• Consolidated Net Profit: ₹82.84 crore
• Dividend Recommended: ₹10 per equity share (FY2026)
• Amalgamation Filing Date: June 25, 2026

What to track next

Investors should monitor updates on the NCLT proceedings for the amalgamation. The upcoming annual general meeting will be crucial for dividend approval. Performance in subsequent quarters will also be key to assessing the impact of the restructuring and market conditions.